Functionally modified gelatin microspheres as a growth factor's delivery system: Development and characterization

Polymer Bulletin

Volumn 71, Issue 4, 2014, Pages 1015-1030

  Adhirajan, N ^a,b   Thanavel, R ^a   Naveen, N ^b   Uma, T S ^b   Babu, Mary ^b  

^a KMCH COLLEGE OF PHARMACY   (India)

^b CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

Collagenase; Drug delivery; Gelatin microspheres; HB EGF; Heparin

Indexed keywords

CELL CULTURE; DRUG DELIVERY; MICROSPHERES; POLYSACCHARIDES; PROTEINS; SCAFFOLDS (BIOLOGY);

COLLAGENASE; ENZYMATIC DEGRADATION; FLUORESCENT STAINING; GELATIN MICROSPHERES; HB-EGF; HEPARIN; MOUSE EMBRYONIC FIBROBLASTS; TISSUE ENGINEERING SCAFFOLD;

BIOACTIVITY;

EID: 84899110465     PISSN: 01700839     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00289-014-1108-3     Document Type: Article

References (33)

1. Choi JS, Leong KW, Yoo HS (2008) In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials 29:587-596
2. Cooper DM, Yu EZ, Hennessey P, Ko F, Robson MC (1994) Cryopreserved saphenous vein allografts for below-knee lower extremity revascularization. Ann Surg 219:688-692
3. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK (1996) Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Investig Dermatol 107:743-748
4. Falanga V, Eaglstein WH (1993) The "trap" hypothesis of venous ulceration. Lancet 341:1006-1008
5. Higley HR, Ksander GA, Gerhardt CO, Falanga V (1995) Extravasation of macromolecules and possible trapping of transforming growth factor-β in venous ulceration. Br J Dermatol 132:79-85
6. Robson MC, Mustoe TA, Hunt TK (1998) The future of recombinant growth factors in wound healing. Am J Surg 176:80S-82S
7. Bennett SP, Griffiths GD, Schor AM, Leese GP, Schor SL (2003) Growth factors in the treatment of diabetic foot ulcers. Br J Surg 90:133-146
8. Smiell JM, Wieman TJ, Steed DL, Perry BH, Sambson AR, Schwab BH (1999) Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 7:335-346
9. Andreopoulos FM, Persaud I (2006) Delivery of basic fibroblast growth factor (bFGF) from photoresponsive hydrogel scaffolds. Biomaterials 27:2468-2476
10. Zhu XH, Tabata Y, Wang HH, Tong Y (2008) Delivery of basic fibroblast growth factor from gelatin microsphere scaffold for the growth of human umbilical vein endothelial cells. Tissue Eng Part A 14:1939-1947
11. Gospodarowicz D, Cheng J (1986) Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128:475-484
12. Wissink MJB, Beernink R, Pieper JS, Poot AA, Engbers GHM, Beugeling T, Van Aken WG, Feijen J (2001) Binding and release of basic fibroblast growth factor from heparinized collagen matrices. Biomaterials 22:2291-2299
13. Tanihara M, Suzuki Y, Yamamoto E, Noguchi A, Mizushima Y (2001) Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate. J Biomed Mater Res 56:216-221
14. Chung Y, Tae G, Yuk SH (2006) A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors. Biomaterials 27:2621-2626
15. Lee JS, Go DH, Bae JW, Lee SJ, Park KD (2007) Heparin conjugated polymeric micelle for long-term delivery of basic fibroblast growth factor. J Control Release 117:204-209
16. Tabata Y, Hijikata S, Ikada Y (1994) A novel skeletal drug delivery system using self-setting bioactive glass bone cement. III: the in vitro drug release from bone cement containing indomethacin and its physicochemical properties. J Control Release 31:111-119
17. Morimoto K, Chono S, Kosai T (2008) Design of cationic microspheres based on aminated gelatin for controlled release of peptide and protein drugs. Drug Deliv 15:113-117
18. Kosasih A, Bowman BJ, Wigent RJ, Ofner CM (2000) Characterization and in vitro release of methotrexate from gelatin/methotrexate conjugates formed using different preparation variables. Int J Pharm 204:81-89
19. Wang J, Tabata Y, Morimoto K (2006) Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats. J Control Release 113:31-37
20. Tabata Y, Ikada Y (1998) Protein release from gelatin matrices. Adv Drug Deliv Rev 31:287-301
21. Adhirajan N, Shanmugasundaram N, Shanmuganathan S, Babu M (2009) Functionally modified gelatin microspheres impregnated collagen scaffold as novel wound dressing to attenuate the proteases and bacterial growth. Eur JPharm Sci 36:235-245
22. Radulescu A, Zhang H, Chen CL, Chen Y, Zhou Y, Yu X, Otabor L, Olson JK, Besner GE (2011) Heparin-binding EGF-like growth factor promotes intestinal anastomotic healing. J Surg Res 171:540-550
23. Adhirajan N, Shanmugasundaram N, Babu M (2007) Gelatin microspheres cross-linked with EDC as a drug delivery system for doxycycline: development and characterization. J Microencapsul 24:659-671
24. Smith PK, Mallia S, Hermanson GT (1980) Colorimetric method for the assay of heparin content in immobilized heparin preparations. Anal Biochem 109:466-473
25. Olde D, Dijkstra PJ, Van Luyn VKA, Van Wachem PB, Nieuwenhuis P, Feijen J (1996) Cross-linking of dermal sheep collagen using a water-soluble carbodiimide. Biomaterials 17:765-773
26. Kuijpers AJ, Engbers GHM, Krijgsveld J, Zaat SAJ, Dankert J, Feijen J (2000) Cross-linking and characterisation of gelatin matrices for biomedical applications. J Biomater Sci Polym Ed 11:225-243
27. van Kuppervelt TM, Veerkamp JH (1994) Application of cationic probes for the ultrastructural localization of proteoglycans in basement membranes. Microsc Res Techn 28:125-140
28. Nimni ME, Harkness RD (1988) Molecular structure and function of collagen. In: Nimni ME (ed) Collagen, vol I. CRC Press, Boca Raton, pp 1-77
29. Yao C, Roderfeld M, Rath T, Roeb E, Bernhagen J, Steffens G (2006) The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matrices. Biomaterials 27:1608-1616
30. Dogan AK, Gumusderelioglu M, Aksoz E (2005) Controlled release of EGF and bFGF from dextran hydrogels in vitro and in vivo. J Biomed Mater Res B Appl Biomater 74:504-510
31. Kanematsu A, Yamamoto S, Ozeki M, Noguchi T, Kanatani I, Ogawa O, Tabata Y (2004) Collagenous matrices as release carriers of exogenous growth factors. Biomaterials 25:4513-4520
32. Raab G, Klagsbrun M (1997) Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1333:F179-F185
33. Berner G, Higashiyama S, Klagsbrun M (1990) Isolation and characterization of a macrophage-derived heparin-binding growth factor. Cell Regul 1:811-819